[1]
Marson, J. and Lebwohl, M. 2021. Apremilast as an Off-Label Therapeutic Agent: A Comprehensive Review of Safety and Efficacy Data in the Literature for Combination Therapy and Inflammatory Dermatoses. SKIN The Journal of Cutaneous Medicine. 5, 3 (May 2021), 203–227. DOI:https://doi.org/10.25251/skin.5.3.2.